Fine‐needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next‐generation sequencing in cancer patients included in the SHIVA02 trial

Author:

Dupain Célia1ORCID,Masliah‐Planchon Julien2,Gu Céline3,Girard Elodie4,Gestraud Pierre4,Du Rusquec Pauline1,Borcoman Edith1,Bello Diana1,Ricci Francesco1,Hescot Ségolène1,Sablin Marie‐Paule1,Tresca Patricia1,Moura Alexandre1,Loirat Delphine1,Frelaut Maxime1,Vincent‐Salomon Anne3,Lecerf Charlotte1ORCID,Callens Céline2,Antonio Samantha2,Franck Coralie2,Mariani Odette3,Bièche Ivan25,Kamal Maud1,Le Tourneau Christophe146,Servois Vincent7

Affiliation:

1. Department of Drug Development and Innovation (D3i) Institut Curie Paris & Saint‐Cloud France

2. Department of Genetics Institut Curie PSL Research University Paris France

3. Department of Pathology Institut Curie PSL Research University Paris France

4. INSERM U900 Research Unit Institut Curie Saint‐Cloud France

5. INSERM U1016 Faculty of Pharmaceutical and Biological Sciences Paris Descartes University Paris France

6. Paris‐Saclay University Paris France

7. Department of Radiology Institut Curie PSL Research University Paris & Saint‐Cloud France

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3